Alterity Therapeutics (PRNAD) Stock Price, News & Analysis
Company Description
This page collects what Stock Titan holds for PRNAD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Latest News
SEC Filings
Alterity Therapeutics has filed 5 recent SEC filings, including 5 Form 6-K. The most recent filing was submitted on July 9, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PRNAD SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Alterity Therapeutics (PRNAD) currently stands at 10.5 thousand shares, up 525750.0% from the previous reporting period, representing 0.0% of the float. Since June 2026, short interest has increased by 525750.0%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Alterity Therapeutics (PRNAD) currently stands at 1000.0 days, up 49899.5% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 49899.5% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 2.0 to 1000.0 days.